These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5740297)

  • 21. Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection.
    Berstad A; Hatlebakk JG; Wilhelmsen I; Berstad K; Bang CJ; Nysaeter G; Hausken T; Weberg R; Nesje LB; Hjartholm AS
    Hepatogastroenterology; 1995; 42(5):655-9. PubMed ID: 8751230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An endoscopic evaluation of gastric ulcer treated with a mixture containing bismuth ammonium citrate.
    Lanza FL
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):779-88. PubMed ID: 4994682
    [No Abstract]   [Full Text] [Related]  

  • 23. Pilot trial of a colloidal bismuth preparation in the treatment of peptic ulcer.
    Weiss G; Kallmeyer JC
    S Afr Med J; 1968 Mar; 42(13):317-20. PubMed ID: 4869603
    [No Abstract]   [Full Text] [Related]  

  • 24. [The treatment of duodenal ulcer with bismuth].
    VON BOROS J; KOHLER R
    Ther Ggw; 1954 Jun; 93(6):216-9. PubMed ID: 13187471
    [No Abstract]   [Full Text] [Related]  

  • 25. [The new possibilities for improving peptic ulcer therapy with the use of probiotic drugs].
    Iarovenko II; Golofeevskiĭ VIu; Sitkin SI
    Voen Med Zh; 2007 Mar; 328(3):17-22. PubMed ID: 17580472
    [No Abstract]   [Full Text] [Related]  

  • 26. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
    Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease.
    Wilhelmsen I; Weberg R; Berstad K; Hausken T; Hundal O; Berstad A
    Hepatogastroenterology; 1994 Feb; 41(1):43-7. PubMed ID: 8175114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical, radiological and endoscopic evaluation of the use of plasmutan in gastro-intestinal ulcerous diseases].
    Bergeron P; Gorce D; Tournier C; Tournut B
    Med Chir Dig; 1975; 4(4):264-5. PubMed ID: 1207205
    [No Abstract]   [Full Text] [Related]  

  • 29. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on a new protective agent of gastro-duodenal mucous membrane].
    Sardet MB; Ruas J
    J Med Bord; 1967 Aug; 144(8):1188-97. PubMed ID: 5619385
    [No Abstract]   [Full Text] [Related]  

  • 31. Absence of in vivo and in vitro interactions of an aluminum hydroxide, magnesium hydroxide containing antacid with cimetidine in patients with peptic ulcer.
    Allgayer H; Röllinghoff W; Paumgartner G
    Z Gastroenterol; 1983 Jul; 21(7):351-4. PubMed ID: 6613216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers.
    Hundal O; Bergseth M; Gharehnia B; Andersen KJ; Berstad A
    Hepatogastroenterology; 1999; 46(29):2882-6. PubMed ID: 10576366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year].
    Berstad A; Berstad K; Hatlebakk JG; Wilhelmsen I; Nysaeter G; Bang CJ; Hausken T; Nesje LB; Hjartholm AS; Hundal O
    Tidsskr Nor Laegeforen; 1994 Sep; 114(21):2477-9. PubMed ID: 7940447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of gastroduodenal ulcers with a new anti-inflammatory and cicatrizing agent].
    Alcalde Gonzalez DR
    Rev Esp Enferm Apar Dig; 1966 Nov; 25(9):1052-68. PubMed ID: 5997897
    [No Abstract]   [Full Text] [Related]  

  • 36. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
    Fedotin MS
    Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of Helicobacter pylori infection: current status].
    Wagner S; Gebel M; Manns M
    Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hospital and ambulatory treatment of patients with uncomplicated peptic ulcer].
    Ivashkin VT; Minasian GA
    Klin Med (Mosk); 1987 May; 65(5):64-70. PubMed ID: 3613484
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of a new antacid, synthetic hydrotalcite, in duodenal ulcer: clinical endoscopic study compared to cimetidine].
    Piai G; Cimino L; D'Argenio G; Mazzacca G
    Clin Ter; 1980 Nov; 95(3):269-77. PubMed ID: 7214842
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experience with hyperbaric oxygenation in treatment of patients with peptic ulcer].
    Komarov FI; Efwni SN; Gorbatenko VP; Filimonov RM; Pogromov AP
    Klin Med (Mosk); 1977 Apr; 55(4):29-32. PubMed ID: 865049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.